Prestalia
- Product NDC
- 72931-011
- Requested package NDC
- 72931-011-03
- 11-digit product format
- 729310011
- Labeler code
- 72931
- Product ID
- 72931-011_cc9b436d-0d79-47c6-b001-878fcb233384
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- perindopril arginine and amlodipine besylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Adhera Therapeutics, Inc.
- Application
- NDA205003
- Marketing category
- NDA
- Marketing start
- 2015-01-26
- Marketing end
- 0000-00-00
- Substance
- PERINDOPRIL ARGININE; AMLODIPINE BESYLATE
- Active strength
- 7 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 72931-011 | 72931-011-03 | I | Inactivated by FDA | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | 1332a3947898… | d4bfe170f9cd… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N205003-001 | PRESTALIA | AMLODIPINE BESYLATE; PERINDOPRIL ARGININE | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | |
| N205003-002 | PRESTALIA | AMLODIPINE BESYLATE; PERINDOPRIL ARGININE | EQ 5MG BASE;7MG | TABLET / ORAL | RLD | 2015-01-21 | |
| N205003-003 | PRESTALIA | AMLODIPINE BESYLATE; PERINDOPRIL ARGININE | EQ 10MG BASE;14MG | TABLET / ORAL | RLD | 2015-01-21 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 |
| N205003-002 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 |
| N205003-003 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N205003-001 | PRESTALIA | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N205003-002 | PRESTALIA | EQ 5MG BASE;7MG | TABLET / ORAL | RLD | 2015-01-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N205003-003 | PRESTALIA | EQ 10MG BASE;14MG | TABLET / ORAL | RLD | 2015-01-21 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N205003-001 | PRESTALIA | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N205003-002 | PRESTALIA | EQ 5MG BASE;7MG | TABLET / ORAL | RLD | 2015-01-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N205003-003 | PRESTALIA | EQ 10MG BASE;14MG | TABLET / ORAL | RLD | 2015-01-21 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205003-001 | PRESTALIA | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205003-002 | PRESTALIA | EQ 5MG BASE;7MG | TABLET / ORAL | RLD | 2015-01-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205003-003 | PRESTALIA | EQ 10MG BASE;14MG | TABLET / ORAL | RLD | 2015-01-21 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205003-001 | PRESTALIA | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205003-002 | PRESTALIA | EQ 5MG BASE;7MG | TABLET / ORAL | RLD | 2015-01-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205003-003 | PRESTALIA | EQ 10MG BASE;14MG | TABLET / ORAL | RLD | 2015-01-21 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205003-001 | PRESTALIA | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205003-002 | PRESTALIA | EQ 5MG BASE;7MG | TABLET / ORAL | RLD | 2015-01-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205003-003 | PRESTALIA | EQ 10MG BASE;14MG | TABLET / ORAL | RLD | 2015-01-21 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205003-001 | PRESTALIA | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205003-002 | PRESTALIA | EQ 5MG BASE;7MG | TABLET / ORAL | RLD | 2015-01-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205003-003 | PRESTALIA | EQ 10MG BASE;14MG | TABLET / ORAL | RLD | 2015-01-21 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205003-001 | PRESTALIA | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205003-002 | PRESTALIA | EQ 5MG BASE;7MG | TABLET / ORAL | RLD | 2015-01-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205003-003 | PRESTALIA | EQ 10MG BASE;14MG | TABLET / ORAL | RLD | 2015-01-21 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205003-001 | PRESTALIA | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205003-002 | PRESTALIA | EQ 5MG BASE;7MG | TABLET / ORAL | RLD | 2015-01-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205003-003 | PRESTALIA | EQ 10MG BASE;14MG | TABLET / ORAL | RLD | 2015-01-21 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205003-001 | PRESTALIA | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205003-002 | PRESTALIA | EQ 5MG BASE;7MG | TABLET / ORAL | RLD | 2015-01-21 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205003-003 | PRESTALIA | EQ 10MG BASE;14MG | TABLET / ORAL | RLD | 2015-01-21 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205003-001 | PRESTALIA | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205003-002 | PRESTALIA | EQ 5MG BASE;7MG | TABLET / ORAL | RLD | 2015-01-21 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205003-003 | PRESTALIA | EQ 10MG BASE;14MG | TABLET / ORAL | RLD, RS | 2015-01-21 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205003-001 | PRESTALIA | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205003-002 | PRESTALIA | EQ 5MG BASE;7MG | TABLET / ORAL | RLD | 2015-01-21 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205003-003 | PRESTALIA | EQ 10MG BASE;14MG | TABLET / ORAL | RLD | 2015-01-21 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N205003-001 | PRESTALIA | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N205003-002 | PRESTALIA | EQ 5MG BASE;7MG | TABLET / ORAL | RLD | 2015-01-21 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N205003-003 | PRESTALIA | EQ 10MG BASE;14MG | TABLET / ORAL | RLD | 2015-01-21 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N205003-001 | PRESTALIA | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N205003-002 | PRESTALIA | EQ 5MG BASE;7MG | TABLET / ORAL | RLD | 2015-01-21 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N205003-003 | PRESTALIA | EQ 10MG BASE;14MG | TABLET / ORAL | RLD, RS | 2015-01-21 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N205003-001 | PRESTALIA | EQ 2.5MG BASE;3.5MG | TABLET / ORAL | RLD | 2015-01-21 | 301d65b070ca… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205003-002 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205003-003 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205003-002 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205003-003 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N205003-002 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N205003-003 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205003-002 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205003-003 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205003-002 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205003-003 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205003-002 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205003-003 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205003-002 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205003-003 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205003-002 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205003-003 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205003-002 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205003-003 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205003-002 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205003-003 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205003-002 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205003-003 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N205003-002 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N205003-003 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N205003-002 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N205003-003 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N205003-001 | 7846961 | 2029-10-05 | U-3 | Drug substance, Drug product | 2015-12-29 | 301d65b070ca… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fa898d56-9495-d6f0-309b-68a5d8e3914a | Product name | 4 | 20260305 |
| c19ec24d-2c40-4b8d-7c20-500ffa3660a1 | Product name | 3 | 20260303 |
| b15e9aa6-d523-ca97-480e-570e0543a342 | Product name | 4 | 20251024 |
| 265792b3-b999-c010-7364-a7db20b9d4d9 | Product name | 5 | 20250515 |
| 14c2c15b-f823-4ada-a40e-a440544294dc | Product name | 1 | 20221207 |
| a72887ef-d675-499f-af4b-78688f6855cd | Product name | 1 | 20191002 |
| a4484670-2869-6416-f6ff-03b1b3cbd1b0 | Product name | 2 | 20190415 |
| 4a27501f-a987-48a5-99b4-e983d4744d76 | Product name | 7 | 20181211 |
| 18600d07-613d-bf9c-2711-fe40c06f3393 | Product name | 5 | 20180703 |
| bded1554-44de-900a-5297-403365d6d4b2 | Product name | 3 | 20170110 |
| 1f1c6e4b-bbad-4649-afd1-7a1d671db4b1 | Product name | 1 | 20150316 |
| b7225d76-59fc-c13f-c287-78d1c893ca87 | Product name | 2 | 20150206 |
| 63ab5fbf-2a6b-c41d-051a-39e845d718b1 | Product name | 1 | 20140508 |
| 7613b1a5-acb6-4e5e-6048-c44deeeb1212 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72931-011-02 | Prestalia | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 1 | |
| 72931-011-03 | Prestalia | 7 in 1 BOTTLE | TABLET | 7 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72931-011-02 | EA - Each | 72931-011 | 0f2e3bfa-662c-4c81-b4d2-5a9594d60e6f | 1 | 2019-11-12 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1600716 | perindopril arginine 14 MG / amLODIPine 10 MG Oral Tablet | PSN | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600724 | perindopril arginine 3.5 MG / amLODIPine 2.5 MG Oral Tablet | PSN | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600728 | perindopril arginine 7 MG / amLODIPine 5 MG Oral Tablet | PSN | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600722 | Prestalia 14 MG / 10 MG Oral Tablet | PSN | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600726 | Prestalia 3.5 MG / 2.5 MG Oral Tablet | PSN | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600730 | Prestalia 7 MG / 5 MG Oral Tablet | PSN | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600722 | amlodipine 10 MG / perindopril arginine 14 MG Oral Tablet [Prestalia] | SBD | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600726 | amlodipine 2.5 MG / perindopril arginine 3.5 MG Oral Tablet [Prestalia] | SBD | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600730 | amlodipine 5 MG / perindopril arginine 7 MG Oral Tablet [Prestalia] | SBD | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600716 | amlodipine 10 MG / perindopril arginine 14 MG Oral Tablet | SCD | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600724 | amlodipine 2.5 MG / perindopril arginine 3.5 MG Oral Tablet | SCD | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600728 | amlodipine 5 MG / perindopril arginine 7 MG Oral Tablet | SCD | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600716 | amlodipine 10 MG (as amlodipine besylate 13.87 MG) / perindopril arginine 14 MG (perindopril 9.51 MG) Oral Tablet | SY | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600724 | amlodipine 2.5 MG (as amlodipine besylate 3.47 MG) / perindopril arginine 3.5 MG (perindopril 2.38 MG) Oral Tablet | SY | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600728 | amlodipine 5 MG (as amlodipine besylate 6.94 MG) / perindopril arginine 7 MG (perindopril 4.76 MG) Oral Tablet | SY | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600722 | Prestalia (amlodipine 10 MG (as amlodipine besylate 13.87 MG) / perindopril arginine 14 MG (perindopril 9.51 MG)) Oral Tablet | SY | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600726 | Prestalia (amlodipine 2.5 MG (as amlodipine besylate 3.47 MG) / perindopril arginine 3.5 MG (perindopril 2.38 MG)) Oral Tablet | SY | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600730 | Prestalia (amlodipine 5 MG (as amlodipine besylate 6.94 MG) / perindopril arginine 7 MG (perindopril 4.76 MG)) Oral Tablet | SY | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600722 | Prestalia 14 MG / 10 MG Oral Tablet | SY | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600726 | Prestalia 3.5 MG / 2.5 MG Oral Tablet | SY | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
| 1600730 | Prestalia 7 MG / 5 MG Oral Tablet | SY | eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 72931-011-03 | 72931001103 | 7 TABLET in 1 BOTTLE (72931-011-03) | 7 tablet | 2018-05-03 | 0000-00-00 | No | No | Current |